A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

NCT04703374 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD

Interventions

DRUG: CKD-382(formulation I)
DRUG: CKD-382(formulation II)
DRUG: D026

Sponsor

Chong Kun Dang Pharmaceutical